The ethics of biobanks

Cambridge Quarterly of Healthcare Ethics

Volumn 13, Issue 4, 2004, Pages 319-326

  Hansson, Sven Ove ^a  

^a ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGY; BIOMEDICINE; CLINICAL PRACTICE; COMMODIFICATION; DNA SEQUENCE; ETHICS; GENETICS; HEALTH CARE; INFORMED CONSENT; INSURANCE; INTERNET; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; PATHOLOGIST; POPULATION; PRACTICE GUIDELINE; PREVENTIVE MEDICINE; PSYCHOLOGICAL ASPECT; REVIEW; RISK ASSESSMENT; SURGICAL TECHNIQUE;

EID: 7044231098     PISSN: 09631801     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0963180104134038     Document Type: Review

References (47)

1. Reymond MA, Steinert R, Escourrou J, Fourtanier G. Ethical, legal, and economical issues raised by the use of human tissue in postgenomic research. Digestive Diseases 2002;20:257-65.
2. Ashcroft R. The ethics of reusing archived tissue for research. Neuropathology and Applied Neurobiology 2000;26:408-11.
3. See note 2, Ashcroft 2000.
4. Kaiser J. Population databases boom, from Iceland to the U.S. Science 2002;298:1158-61; Abbott A. Sweden sets ethical standards for use of genetic "biobanks." Nature 1999;400:3.
5. Kaiser J. Population databases boom, from Iceland to the U.S. Science 2002;298:1158-61; Abbott A. Sweden sets ethical standards for use of genetic "biobanks." Nature 1999;400:3.
6. Hauksson P. Icelanders opt out of genetic databases. Nature 1999;400:707-8.
7. Stegmayr B, Asplund K. Genetisk forskning på blodprov som förvarats länge i medicinsk biobank: de flesta människor är positiva till att ge informerat samtycke. Läkartidningen 2003;100:618-20.
8. See note 1, Reymond, Steinert, Escourrou, Fourtanier 2002.
9. See note 4, Kaiser 2002.
10. Womack C, Gray NM. Human research tissue banks in the U.K. national health services: laws, ethics, controls, and constraints. British Journal of Biomedical Science 2000;57:250-3.
11. Skene L. Ownership of human tissue and the law. Nature Reviews Genetics 2002;3:145-8; Wood J. The role, duties, and responsibilities of technologists in the clinical laboratory. Clinica Chimica Acta 2002;319:127-2.
12. Skene L. Ownership of human tissue and the law. Nature Reviews Genetics 2002;3:145-8; Wood J. The role, duties, and responsibilities of technologists in the clinical laboratory. Clinica Chimica Acta 2002;319:127-2.
13. Lawrence SC. Beyond the grave. In: Weir RF, ed. Stored Tissue Samples: Ethical, Legal, and Public Policy Implications. Iowa City: University of Iowa Press; 1998:111-42.
14. See note 9, Womack, Gray 2000.
15. Enosawa S, Suzuki S, Amemiya H, Tsuchihashi N, Kawashiro N, Utsugi S et al. Establishment of public human tissue resource bank for research purposes with surgically removed tonsil tissue: potential scientific value and ethical problem. Transplantation Proceedings 2002;34:2686-7.
16. See note 6, Stegmayr, Asplund 2003.
17. See note 2, Ashcroft 2000.
18. See note 6, Stegmayr, Asplund 2003.
19. O'Brien J, Chantler C. Confidentiality and the duties of care. Journal of Medical Ethics 2003;29:36-40.
20. Dillner J. Danska biobanksutredningen föreslår "avhopps"-register. Läkartidningen 2002;88:4384-5.
21. See note 4, Kaiser 2002; see note 2, Ashcroft 2000.
22. See note 9, Womack, Gray 2000.
23. See note 4, Abbott 1999.
24. Brady T. The ethical implications of the Human Genome Project for the workplace. International Journal of Applied Philosophy 1995;10:47-56.
25. Alper JS, Beckwith J. Distinguishing genetic from nongenetic medical tests: some implications for antidiscrimination legislation. Science and Engineering Ethics 1998;4:141-50; Alper JS, Beckwith J. On the philosophical analysis of genetic essentialism: commentary on: "The use of genetic test information in insurance: the argument from indistinguishability reconsidered." Science and Engineering Ethics 2000;6:311-4; Launis V. The use of genetic test information in insurance: the argument from indistinguishability reconsidered. Science and Engineering Ethics 2000;6:299-310; Cook ED. Genetics and the British insurance industry. Journal of Medical Ethics 1999;25:157-62.
26. Alper JS, Beckwith J. Distinguishing genetic from nongenetic medical tests: some implications for antidiscrimination legislation. Science and Engineering Ethics 1998;4:141-50; Alper JS, Beckwith J. On the philosophical analysis of genetic essentialism: commentary on: "The use of genetic test information in insurance: the argument from indistinguishability reconsidered." Science and Engineering Ethics 2000;6:311-4; Launis V. The use of genetic test information in insurance: the argument from indistinguishability reconsidered. Science and Engineering Ethics 2000;6:299-310; Cook ED. Genetics and the British insurance industry. Journal of Medical Ethics 1999;25:157-62.
27. Alper JS, Beckwith J. Distinguishing genetic from nongenetic medical tests: some implications for antidiscrimination legislation. Science and Engineering Ethics 1998;4:141-50; Alper JS, Beckwith J. On the philosophical analysis of genetic essentialism: commentary on: "The use of genetic test information in insurance: the argument from indistinguishability reconsidered." Science and Engineering Ethics 2000;6:311-4; Launis V. The use of genetic test information in insurance: the argument from indistinguishability reconsidered. Science and Engineering Ethics 2000;6:299-310; Cook ED. Genetics and the British insurance industry. Journal of Medical Ethics 1999;25:157-62.
28. Alper JS, Beckwith J. Distinguishing genetic from nongenetic medical tests: some implications for antidiscrimination legislation. Science and Engineering Ethics 1998;4:141-50; Alper JS, Beckwith J. On the philosophical analysis of genetic essentialism: commentary on: "The use of genetic test information in insurance: the argument from indistinguishability reconsidered." Science and Engineering Ethics 2000;6:311-4; Launis V. The use of genetic test information in insurance: the argument from indistinguishability reconsidered. Science and Engineering Ethics 2000;6:299-310; Cook ED. Genetics and the British insurance industry. Journal of Medical Ethics 1999;25:157-62.
29. Silvers A, Stein MA. An equality paradigm for preventing genetic discrimination. Vanderbilt Law Review 2002;55:1341-499; Persson AP, Hansson SO. Privacy at work: ethical criteria. Journal of Business Ethics 2003;42:59-70.
30. Silvers A, Stein MA. An equality paradigm for preventing genetic discrimination. Vanderbilt Law Review 2002;55:1341-499; Persson AP, Hansson SO. Privacy at work: ethical criteria. Journal of Business Ethics 2003;42:59-70.
31. Green MJ, Botkin RJ. "Genetic exceptionalism" in medicine: clarifying the differences between genetic and nongenetic tests. Annals of Internal Medicine 2003;138(7):571-5.
32. See note 1, Reymond, Steinert, Escourrou, Fourtanier 2002.
33. See note 4, Kaiser 1999.
34. See note 1, Reymond, Steinert, Escourrou, Fourtanier 2002; see note 10, Skene 2002.
35. See note 10, Skene 2002; see also: Swain MS, Marusyk RW. An alternative to property rights in human tissues. Hastings Center Report 1990;:12-5.
36. Radin MJ. Contested Commodities. Cambridge, MA: Harvard University Press; 1996; Jansen R. Sperm and ova as property. Journal of Medical Ethics 1985;11:123-26; Macer D. New creations? commentary. Hastings Center Report 1991;91:32-3.
37. Radin MJ. Contested Commodities. Cambridge, MA: Harvard University Press; 1996; Jansen R. Sperm and ova as property. Journal of Medical Ethics 1985;11:123-26; Macer D. New creations? commentary. Hastings Center Report 1991;91:32-3.
38. Radin MJ. Contested Commodities. Cambridge, MA: Harvard University Press; 1996; Jansen R. Sperm and ova as property. Journal of Medical Ethics 1985;11:123-26; Macer D. New creations? commentary. Hastings Center Report 1991;91:32-3.
39. Macklin R. Splitting embryos on the slippery slope: ethics and public policy. Kennedy Institute of Ethics Journal 1994;4(3):209-25.
40. Cahill LS. Genetics, commodification, and social justice in the globalization era. Kennedy Institute of Ethics Journal 2001;11(3):221-38; Hanson M. Biotechnology and commodification within health. Journal of Medicine and Philosophy 1999;24(3):267-87.
41. Cahill LS. Genetics, commodification, and social justice in the globalization era. Kennedy Institute of Ethics Journal 2001;11(3):221-38; Hanson M. Biotechnology and commodification within health. Journal of Medicine and Philosophy 1999;24(3):267-87.
42. Crespi RS. An analysis of moral issues affecting patenting inventions in the life sciences: a European perspective. Science and Engineering Ethics 2000;6:157-80.
43. Grisolia JS. CNS stem cell transplantation: clinical and ethical perspectives. Brain Research Bulletin 2002;57:823-6.
44. Resnik D. Regulating the market for human eggs. Bioethics 2001;15(1):1-25.
45. Cherry M. Is a market in human organs necessarily exploitative? Public Affairs Quarterly 2000;14(4):337-60.
46. See note 4, Abbott 1999; see also: Nilsson A, Rose J. Sweden takes steps to protect tissue banks. Science 1999;286:894. Available at: http://www.mrc.ac.uk; see note 9, Womack, Gray 2000.
47. See note 1, Reymond, Steinert, Escourrou, Fourtanier 2002.